Star Lake Bioscience Co., Inc.Zhaoqing Guangdong (SHA:600866)
China
· Delayed Price · Currency is CNY 6.28
+0.03 (0.48%)
Apr 29, 2026, 3:00 PM CST
SHA:600866 Revenue
In the year 2025, Star Lake Bioscience Co., Inc.Zhaoqing Guangdong had annual revenue of 15.90B CNY, down -8.27%. Star Lake Bioscience Co., Inc.Zhaoqing Guangdong had revenue of 3.82B in the quarter ending December 31, 2025, a decrease of -15.89%.
Revenue
15.90B
Revenue Growth
-8.27%
P/S Ratio
0.66
Revenue / Employee
1.71M
Employees
9,293
Market Cap
10.43B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 15.90B | -1.43B | -8.27% |
| Dec 31, 2024 | 17.33B | -39.32M | -0.23% |
| Dec 31, 2023 | 17.37B | -112.59M | -0.64% |
| Dec 31, 2022 | 17.49B | 13.42B | 329.51% |
| Dec 31, 2021 | 4.07B | 2.95B | 264.72% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| HitGen | 525.57M |
| Jiangxi Fushine Pharmaceutical | 1.31B |
| Beijing Hotgen Biotech | 404.88M |
| Liaoning Chengda Biotechnology | 1.39B |
| Chengdu Easton Biopharmaceuticals | 1.35B |
| Aurisco Pharmaceutical | 1.68B |
| Chongqing Genrix Biopharmaceutical | 230.72M |
| Hualan Biological Vaccine | 1.20B |